See more : CLC Industries Limited (SPENTEX.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Science in Sport plc (SIS.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Science in Sport plc, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- Empresa Distribuidora y Comercializadora Norte Sociedad Anónima (EDN.BA) Income Statement Analysis – Financial Results
- Andover Bancorp, Inc. (ANDC) Income Statement Analysis – Financial Results
- Jiangsu Shuangxing Color Plastic New Materials Co., Ltd. (002585.SZ) Income Statement Analysis – Financial Results
- StandardAero, Inc. (SARO) Income Statement Analysis – Financial Results
- Bass Oil Limited (BAS.AX) Income Statement Analysis – Financial Results
Science in Sport plc (SIS.L)
About Science in Sport plc
Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; supplements; and vitamins. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains; specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, third-party online sites in the United Kingdom, rest of Europe, the United States, and internationally. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 62.67M | 63.77M | 62.54M | 50.35M | 50.57M | 21.32M | 15.62M | 12.24M | 9.45M | 8.46M | 6.85M | 5.52M | 4.63M |
| Cost of Revenue | 35.84M | 36.84M | 31.19M | 25.76M | 28.37M | 9.36M | 6.30M | 4.87M | 3.93M | 3.49M | 2.95M | 2.44M | 2.12M |
| Gross Profit | 26.83M | 26.94M | 31.35M | 24.60M | 22.21M | 11.96M | 9.32M | 7.38M | 5.52M | 4.97M | 3.90M | 3.08M | 2.52M |
| Gross Profit Ratio | 42.81% | 42.24% | 50.13% | 48.85% | 43.91% | 56.08% | 59.65% | 60.26% | 58.43% | 58.75% | 56.91% | 55.79% | 54.34% |
| Research & Development | 840.00K | 249.00K | 693.00K | 383.00K | 232.00K | 320.00K | 339.00K | 337.00K | 223.00K | 237.00K | 0.00 | 151.09K | 0.00 |
| General & Administrative | 16.33M | 14.08M | 10.41M | 9.07M | 5.15M | 3.75M | 3.04M | 2.25M | 2.09M | 3.15M | 2.31M | 1.47M | 1.07M |
| Selling & Marketing | 13.99M | 17.61M | 19.63M | 14.37M | 17.53M | 10.75M | 7.98M | 5.93M | 3.69M | 3.21M | 2.76M | 1.79M | 1.32M |
| SG&A | 30.32M | 17.61M | 19.63M | 14.37M | 22.68M | 14.50M | 11.02M | 8.18M | 5.77M | 6.36M | 5.07M | 3.26M | 2.39M |
| Other Expenses | 0.00 | 19.15M | 16.94M | 12.46M | 3.94M | 2.85M | 2.15M | 1.99M | 1.36M | 0.00 | 0.00 | 0.00 | -6.57K |
| Operating Expenses | 36.62M | 36.76M | 36.57M | 26.83M | 26.62M | 17.35M | 13.17M | 10.17M | 7.13M | 6.72M | 5.07M | 3.26M | 2.39M |
| Cost & Expenses | 72.46M | 73.59M | 67.76M | 52.59M | 54.98M | 26.71M | 19.47M | 15.03M | 11.05M | 10.21M | 8.02M | 5.70M | 4.50M |
| Interest Income | 0.00 | 0.00 | 5.00K | 43.00K | 4.00K | 5.00K | 0.00 | 1.00K | 2.00K | 1.00K | 1.82K | 0.00 | 0.00 |
| Interest Expense | 1.56M | 757.00K | 119.00K | 79.00K | 23.00K | 1.19M | 0.00 | 4.00K | 5.00K | 0.00 | 5.84K | 3.28K | 5.88K |
| Depreciation & Amortization | 6.25M | 4.81M | 3.63M | 3.17M | 2.77M | 926.00K | 567.00K | 421.00K | 364.00K | 261.50K | 263.06K | 169.91K | 75.93K |
| EBITDA | -3.70M | -5.15M | -1.82M | 846.00K | -2.27M | -5.12M | -3.29M | -2.37M | -1.37M | -2.51M | -908.00K | -12.67K | 208.30K |
| EBITDA Ratio | -5.90% | -7.86% | -2.53% | 1.93% | -3.22% | -18.16% | -21.04% | -19.34% | -13.15% | -16.88% | -13.26% | -0.23% | 4.50% |
| Operating Income | -9.73M | -9.82M | -5.22M | -2.19M | -4.41M | -5.40M | -3.85M | -2.79M | -1.73M | -1.69M | -1.17M | -182.58K | 132.37K |
| Operating Income Ratio | -15.53% | -15.40% | -8.35% | -4.36% | -8.72% | -25.31% | -24.67% | -22.79% | -18.35% | -19.97% | -17.13% | -3.31% | 2.86% |
| Total Other Income/Expenses | -1.56M | -757.00K | -114.00K | -36.00K | -656.00K | -594.00K | 0.00 | -3.00K | -128.00K | -61.00K | -4.14K | -3.28K | -5.88K |
| Income Before Tax | -11.29M | -10.58M | -5.34M | -2.27M | -5.06M | -5.99M | -3.85M | -2.79M | -1.74M | -1.75M | -1.18M | -185.86K | 126.49K |
| Income Before Tax Ratio | -18.02% | -16.59% | -8.53% | -4.51% | -10.01% | -28.10% | -24.67% | -22.81% | -18.38% | -20.69% | -17.19% | -3.37% | 2.73% |
| Income Tax Expense | -12.00K | 332.00K | 1.48M | -545.00K | 554.00K | -115.00K | -246.00K | -149.00K | -227.00K | 460.00K | -218.31K | -88.62K | 16.82K |
| Net Income | -11.28M | -10.91M | -6.82M | -1.73M | -5.62M | -5.88M | -3.61M | -2.64M | -1.51M | -1.29M | -958.57K | -97.24K | 109.67K |
| Net Income Ratio | -18.00% | -17.11% | -10.90% | -3.43% | -11.11% | -27.56% | -23.09% | -21.60% | -15.98% | -15.26% | -14.00% | -1.76% | 2.37% |
| EPS | -0.07 | -0.08 | -0.05 | -0.01 | -0.05 | -0.08 | -0.08 | -0.06 | -0.06 | -0.05 | -0.05 | -0.01 | 0.01 |
| EPS Diluted | -0.07 | -0.08 | -0.05 | -0.01 | -0.05 | -0.08 | -0.08 | -0.06 | -0.06 | -0.05 | -0.05 | -0.01 | 0.01 |
| Weighted Avg Shares Out | 170.12M | 138.86M | 133.52M | 129.37M | 122.72M | 71.42M | 46.70M | 42.53M | 27.40M | 24.09M | 17.94M | 19.38M | 19.38M |
| Weighted Avg Shares Out (Dil) | 170.12M | 138.86M | 133.52M | 129.37M | 122.72M | 71.42M | 46.70M | 42.53M | 27.40M | 24.09M | 17.94M | 19.38M | 19.38M |
Source: https://incomestatements.info
Category: Stock Reports